0,898  0,006  Apoptosis agonist
0,832  0,007  Antineoplastic (breast cancer)
0,821  0,013  Antiinflammatory
0,810  0,008  Antineoplastic (lung cancer)
0,806  0,004  Sensitization
0,794  0,012  Caspase 9 stimulant
0,786  0,005  Prostate cancer treatment
0,761  0,008  Antileukemic
0,737  0,011  TNF expression inhibitor
0,738  0,017  Transcription factor NF kappa B inhibitor
0,699  0,009  Antineoplastic (ovarian cancer)
0,694  0,012  Carcinogenic
0,648  0,020  Teratogen
0,625  0,009  Nitric oxide antagonist
0,623  0,021  Embryotoxic
0,598  0,009  Antineoplastic (glioma)
0,601  0,017  Antihypercholesterolemic
0,585  0,006  Antineoplastic (glioblastoma multiforme)
0,598  0,023  Antineoplastic (colorectal cancer)
0,586  0,012  Antineoplastic (pancreatic cancer)
0,582  0,009  Antifungal
0,591  0,023  Antineoplastic (colon cancer)
0,575  0,013  AR expression inhibitor
0,550  0,003  Abortion inducer
0,554  0,008  Antineoplastic enhancer
0,549  0,013  Antiparasitic
0,553  0,019  Antipruritic, allergic
0,554  0,022  Respiratory analeptic
0,553  0,028  Antibacterial
0,544  0,020  Bone diseases treatment
0,511  0,018  Chemopreventive
0,498  0,024  Antineoplastic (melanoma)
0,483  0,011  Antihelmintic
0,490  0,020  Cardiovascular analeptic
0,479  0,014  UGT2B4 substrate
0,482  0,025  Antineoplastic (cervical cancer)
0,484  0,037  Immunosuppressant
0,453  0,009  Contraceptive
0,468  0,024  NOS3 expression inhibitor
0,444  0,016  Antineoplastic (endocrine cancer)
0,431  0,009  UGT2B7 substrate
0,443  0,029  Analeptic
0,430  0,017  Antineoplastic (osteosarcoma)
0,427  0,015  Antiulcerative
0,415  0,008  Lipocortins synthesis antagonist
0,415  0,009  Antiacne
0,413  0,010  Prostate disorders treatment
0,431  0,035  Hepatic disorders treatment
0,437  0,043  Cholesterol antagonist
0,409  0,014  Sodium/bile acid cotransporter inhibitor
0,400  0,011  Interferon gamma antagonist
0,436  0,051  CYP2C9 substrate
0,411  0,028  Antiprotozoal (Leishmania)
0,393  0,012  Prostatic (benign) hyperplasia treatment
0,380  0,012  Antipruritic, non-allergic
0,390  0,027  Hypolipemic
0,361  0,006  Cholesterol synthesis inhibitor
0,389  0,036  Chemoprotective
0,389  0,041  Lipoprotein disorders treatment
0,365  0,021  UGT1A1 substrate
0,356  0,014  Hair growth stimulant
0,377  0,037  NOS2 expression inhibitor
0,358  0,018  Hepatoprotectant
0,377  0,043  Antiosteoporotic
0,372  0,040  Antioxidant
0,370  0,046  CYP2C19 substrate
0,384  0,067  CYP3A4 substrate
0,354  0,038  Proliferative diseases treatment
0,352  0,037  Tumour necrosis factor alpha release inhibitor
0,353  0,043  Cytotoxic
0,310  0,005  Contraceptive female
0,377  0,073  Antineoplastic (myeloid leukemia)
0,336  0,040  Antineoplastic (renal cancer)
0,345  0,053  Calcium channel activator
0,320  0,028  Growth hormone agonist
0,347  0,060  Caspase 3 stimulant
0,313  0,028  UGT1A4 substrate
0,300  0,018  Neurotrophic factor enhancer
0,293  0,011  UGT2B9 substrate
0,336  0,068  Immunostimulant
0,323  0,055  Hypoxia-inducible factor 1 alpha inhibitor
0,307  0,049  Antineoplastic (liver cancer)
0,327  0,074  ICAM1 expression inhibitor
0,346  0,093  CYP2C19 inhibitor
0,270  0,023  UGT2B15 substrate
0,257  0,016  Antifungal enhancer
0,274  0,035  P-glycoprotein inhibitor
0,249  0,019  Interleukin 1 antagonist
0,278  0,048  Mutagenic
0,271  0,042  UDP-glucuronosyltransferase substrate
0,251  0,023  Interleukin 6 antagonist
0,267  0,040  Antiviral (Influenza)
0,236  0,009  Arachidonic acid antagonist
0,245  0,026  Antiviral (Influenza A)
0,230  0,014  Microtubule formation inhibitor
0,222  0,011  Androgen antagonist
0,239  0,029  Skin irritative effect
0,240  0,031  Anesthetic
0,216  0,008  Adenylate cyclase stimulant
0,199  0,004  Anabolic
0,214  0,028  UGT2B10 substrate
0,219  0,035  Melanin inhibitor
0,203  0,021  Antineoplastic antibiotic
0,186  0,005  UGT2B11 substrate
0,227  0,054  Sigma receptor agonist
0,196  0,023  Farnesoid X receptor antagonist
0,179  0,009  CDC25A inhibitor
0,169  0,002  Postcoital contraceptive
0,200  0,037  Skin whitener
0,183  0,021  Choleretic
0,206  0,047  UGT1A3 substrate
0,174  0,018  TRPA1 agonist
0,258  0,102  CYP2D6 substrate
0,161  0,014  Contraceptive male
0,160  0,014  Transcription factor NF kappa B stimulant
0,299  0,153  Antiarthritic
0,150  0,006  Na+ K+ transporting ATPase inhibitor
0,252  0,108  CTGF expression inhibitor
0,236  0,096  Gastrin inhibitor
0,165  0,026  Alcohol dehydrogenase substrate
0,140  0,004  Squalene synthetase inhibitor
0,213  0,077  Interleukin antagonist
0,241  0,107  Antihypoxic
0,256  0,122  Apoptosis antagonist
0,182  0,049  Protein kinase stimulant
0,137  0,006  Hypercalcemia treatment
0,246  0,119  CYP3A4 inhibitor
0,168  0,040  DNA polymerase I inhibitor
0,139  0,014  Antiprotozoal activity enhancer
0,211  0,086  Peptidyltransferase inhibitor
0,133  0,013  Postmenopausal disorders treatment
0,139  0,020  SULT1E1 substrate
0,147  0,028  Antineoplastic alkaloid
0,152  0,034  Endometrios treatment
0,121  0,004  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,156  0,041  Adenylate cyclase inhibitor
0,117  0,005  Heme oxygenase stimulant
0,203  0,091  Antineoplastic (lymphoma)
0,211  0,100  Antipyretic
0,172  0,061  Protein-tyrosine phosphatase inhibitor
0,135  0,024  Antiviral (Coronavirus)
0,135  0,024  Antiviral (SARS coronavirus)
0,119  0,010  Androgen agonist
0,153  0,044  Protein-tyrosine phosphatase 1B inhibitor
0,171  0,064  Eye irritation, high
0,230  0,125  Antimycobacterial
0,186  0,083  Anesthetic general
0,164  0,060  Antineoplastic (carcinoma)
0,216  0,115  Antituberculosic
0,145  0,045  Growth stimulant
0,135  0,035  Antiinfertility, female
0,105  0,006  RNA-directed RNA polymerase stimulant
0,169  0,075  Toxic, respiratory center
0,172  0,080  Antirickettsial
0,122  0,031  Antispirochetal
0,195  0,105  Cytostatic
0,146  0,057  Cocaine dependence treatment
0,239  0,150  GST A substrate
0,141  0,052  Proteasome inhibitor
0,151  0,068  Lipid peroxidase inhibitor
0,168  0,087  LDLR expression enhancer
0,107  0,027  Glycine receptor antagonist
0,088  0,009  Aldosterone antagonist
0,139  0,060  Carcinogenic, group 3
0,089  0,011  5-Alpha-reductase inhibitor
0,211  0,134  Antineoplastic (multiple myeloma)
0,120  0,045  Sulfotransferase substrate
0,107  0,032  Antibiotic
0,085  0,011  Lipocortins synthesis agonist
0,097  0,027  Narcotic antagonist
0,077  0,009  Adenylate cyclase 1 inhibitor
0,121  0,054  Carcinogenic, group 2B
0,108  0,040  Paget's disease treatment
0,139  0,072  Antineoplastic (squamous cell carcinoma)
0,105  0,039  Ornithine decarboxylase inhibitor
0,120  0,055  Estrogen antagonist
0,131  0,066  Antihyperlipoproteinemic
0,146  0,081  Diuretic
0,146  0,082  Antiviral (Herpes)
0,073  0,012  Progesterone antagonist
0,204  0,143  Antipsoriatic
0,105  0,044  ABCA1 expression enhancer
0,141  0,080  Antimutagenic
0,069  0,009  Glucocorticoid antagonist
0,128  0,070  Vanilloid 1 agonist
0,081  0,024  SULT2A1 substrate
0,079  0,023  Antimycoplasmal
0,166  0,112  Insulin sensitizer
0,074  0,025  Estrogen agonist
0,099  0,052  Bile acid receptor antagonist
0,058  0,013  Parathyroid hormone antagonist
0,064  0,019  Potassium channel Kv1.3 blocker
0,054  0,010  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,106  0,063  UGT2B1 substrate
0,055  0,012  GABA uptake inhibitor
0,181  0,140  5 Hydroxytryptamine release stimulant
0,076  0,038  Anticholelithogenic
0,042  0,005  Vitamin D receptor antagonist
0,196  0,160  5 Hydroxytryptamine uptake stimulant
0,061  0,030  Protein 50S ribosomal subunit inhibitor
0,130  0,100  Antifungal (Cryptococcus)
0,109  0,079  Autism spectrum disorders treatment
0,133  0,104  Ca2+-transporting ATPase inhibitor
0,163  0,136  UGT1A6 substrate
0,072  0,044  Premenstrual syndrome treatment
0,044  0,017  Glucose-6-phosphate dehydrogenase inhibitor
0,084  0,057  3C-Like protease (SARS coronavirus) inhibitor
0,166  0,140  VCAM1 expression inhibitor
0,129  0,103  Pregnane X receptor agonist
0,121  0,095  Psychosexual dysfunction treatment
0,174  0,148  Antihypotensive
0,039  0,014  ATP citrate lysase inhibitor
0,030  0,007  Progesterone agonist
0,045  0,023  Hypogonadism treatment
0,162  0,139  Antineoplastic (non-small cell lung cancer)
0,062  0,040  Aromatase inhibitor
0,177  0,156  Cardioprotectant
0,171  0,150  RNA-directed DNA polymerase inhibitor
0,041  0,020  Estrogen receptor alpha agonist
0,031  0,011  Retinoid X gamma receptor antagonist
0,031  0,011  Hedgehog signaling activator
0,052  0,033  Anesthetic inhalation
0,027  0,009  Corticosteroid-like
0,085  0,067  Actinic keratosis treatment
0,064  0,045  CDC25B inhibitor
0,029  0,011  Retinoid X gamma receptor agonist
0,021  0,006  Vitamin D receptor agonist
0,026  0,012  Estrone sulfatase inhibitor
0,121  0,108  Genotoxic
0,069  0,057  Glycine receptor agonist
0,045  0,034  Microtubule stabilization
0,078  0,066  Inducible nitric-oxide synthase inhibitor
0,021  0,010  Progesterone receptor B antagonist
0,022  0,013  Retinoid X beta receptor agonist
0,139  0,131  Phospholipase C inhibitor
0,150  0,143  Pneumotoxic
0,081  0,075  Tocolytic
0,072  0,065  Antitreponemal
0,039  0,034  Cholesterol absorption inhibitor
0,013  0,007  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,094  0,089  SULT1A1 substrate
0,136  0,131  Angiogenesis stimulant
0,013  0,009  Glucocorticoid agonist
0,089  0,086  Estrogen receptor beta antagonist
0,022  0,019  Retinoic acid receptor agonist
0,142  0,139  Antihypertriglyceridemic
0,021  0,018  Retinoic acid gamma receptor agonist
0,190  0,190  Antithrombotic

